Login / Signup

Patient Safety Outcomes for Continuous Infusion Vancomycin as Outpatient Parenteral Antimicrobial Therapy.

Russell J BenefieldJoshua McDonaldMichael NewmanBrandon TritleLaura K Certain
Published in: Pharmacotherapy (2023)
There was no appreciable benefit of continuous infusion vancomycin on outpatient safety outcomes. AUC-centered dosing approaches warrant further investigation as strategies to improve vancomycin safety in OPAT programs.
Keyphrases
  • patient safety
  • methicillin resistant staphylococcus aureus
  • staphylococcus aureus
  • low dose
  • quality improvement
  • public health
  • stem cells
  • type diabetes
  • adipose tissue
  • skeletal muscle
  • cell therapy